Impact of18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement

Stage Migration, Selection Bias, and Survival Associated With the Adoption of Positron Emission Tomography Among Medicare Beneficiaries With Non–Small-Cell Lung Cancer, 1998-2003

(2012) Michaela A. Dinan et al.   JOURNAL OF CLINICAL ONCOLOGY

Routine Bone Marrow Biopsy Has Little or No Therapeutic Consequence for Positron Emission Tomography/Computed Tomography–Staged Treatment-Naive Patients With Hodgkin Lymphoma

(2012) Tarec Christoffer El-Galaly et al.   JOURNAL OF CLINICAL ONCOLOGY

[18F]Fluorodeoxyglucose Positron Emission Tomography for Detection of Bone Marrow Involvement in Children and Adolescents With Hodgkin's Lymphoma

(2011) Sandra Purz et al.   JOURNAL OF CLINICAL ONCOLOGY

Routine bone marrow biopsy is not necessary in the staging of patients with classical Hodgkin lymphoma in the18F-fluoro-2-deoxyglucose positron emission tomography era

(2011) Simon E. Richardson et al.   LEUKEMIA & LYMPHOMA

18F-FDG PET/CT bone/bone marrow findings in Hodgkin’s lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging

(2010) Gerard Moulin-Romsee et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial

(2010) Hans Theodor Eich et al.   JOURNAL OF CLINICAL ONCOLOGY

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

(2010) Andreas Engert et al.   NEW ENGLAND JOURNAL OF MEDICINE

18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients

(2009) M. Weiler-Sagie et al.   JOURNAL OF NUCLEAR MEDICINE